Publication:
New Quinazolinone-Thiazolidinedione Hybrids as Selective Anti-Lung Cancer Agents and Promising EGFR Inhibitors

dc.contributor.authorTokalı P.
dc.contributor.authorŞenol A. M.
dc.contributor.authorAteşoğlu Ş.
dc.contributor.authorÇakır F.
dc.contributor.authorŞenol H.
dc.contributor.authorTokalı F. S.
dc.contributor.authorAkbaş F.
dc.date.accessioned2026-01-30T21:36:28Z
dc.date.issued2026-02-01
dc.identifier.citationTokalı P., Şenol A. M., Ateşoğlu Ş., Çakır F., Şenol H., Tokalı F. S., Akbaş F., "New Quinazolinone-Thiazolidinedione Hybrids as Selective Anti-Lung Cancer Agents and Promising EGFR Inhibitors", FUTURE MEDICINAL CHEMISTRY, cilt.18, sa.2, ss.1-20, 2026
dc.identifier.issn1756-8919
dc.identifier.issue2
dc.identifier.urihttps://hdl.handle.net/20.500.12645/41664
dc.identifier.volume18
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectEczacılık
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Kimya
dc.subjectYaşam Bilimleri
dc.subjectBiyokimya
dc.subjectMoleküler Biyokimya
dc.subjectKimya
dc.subjectBiyoorganik Kimya
dc.subjectSağlık Bilimleri
dc.subjectOrganik Kimya
dc.subjectHeterosiklik Bileşikler Kimyası
dc.subjectTemel Bilimler
dc.subjectPharmacology and Therapeutics
dc.subjectProfessional Sciences
dc.subjectPharmaceutical Chemistry
dc.subjectLife Sciences
dc.subjectBiochemistry
dc.subjectMolecular Biochemistry
dc.subjectChemistry
dc.subjectBioorganic Chemistry
dc.subjectHealth Sciences
dc.subjectOrganic Chemistry
dc.subjectChemistry of Heterocyclic Compounds
dc.subjectNatural Sciences
dc.subjectKlinik Tıp (Med)
dc.subjectTemel Bilimler (Sci)
dc.subjectYaşam Bilimleri (Life)
dc.subjectBiyoloji ve Biyokimya
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectDoğa Bilimleri Genel
dc.subjectFarmakoloji ve Eczacılık
dc.subjectKimya Organik
dc.subjectKimya Multidisipliner
dc.subjectÇok Disiplinli Bilimler
dc.subjectKimya Tıbbi
dc.subjectBiyokimyasal Araştırma Yöntemleri
dc.subjectClinical Medicine (Med)
dc.subjectNatural Sciences (Sci)
dc.subjectLife Sciences (Life)
dc.subjectBiology & Biochemistry
dc.subjectPharmacology & Toxicology
dc.subjectNatural Sciences General
dc.subjectPharmacology & Pharmacy
dc.subjectChemistry Organic
dc.subjectChemistry Multidisciplinary
dc.subjectMultidisciplinary Sciences
dc.subjectChemistry Medicinal
dc.subjectBiochemical Research Methods
dc.subjectFarmakoloji
dc.subjectFarmakoloji, Toksikoloji ve Eczacılık (çeşitli)
dc.subjectGenel Farmakoloji, Toksikoloji ve Eczacılık
dc.subjectFarmakoloji (tıbbi)
dc.subjectİlaç Rehberleri
dc.subjectKimya (çeşitli)
dc.subjectGenel Kimya
dc.subjectMultidisipliner
dc.subjectFizik Bilimleri
dc.subjectPharmacy
dc.subjectPharmacology
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology (medical)
dc.subjectDrug Guides
dc.subjectChemistry (miscellaneous)
dc.subjectGeneral Chemistry
dc.subjectMultidisciplinary
dc.subjectPhysical Sciences
dc.titleNew Quinazolinone-Thiazolidinedione Hybrids as Selective Anti-Lung Cancer Agents and Promising EGFR Inhibitors
dc.typearticle
dspace.entity.typePublication
local.avesis.id9b2250e8-7dcd-4f83-8b66-d2500f4d8ae9

Files